Cargando…
Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products
Objective: The aim of this study was to compare the moisturising efficacy and acceptability of physical characteristics of two commonly prescribed emollients licenced in the UK, Doublebase Dayleve gel (DELP) and Diprobase cream (DIPC). Methods: The study was a double-blind, concurrent bi-lateral com...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020331/ https://www.ncbi.nlm.nih.gov/pubmed/26864095 http://dx.doi.org/10.3109/09546634.2015.1136384 |
_version_ | 1782453187470426112 |
---|---|
author | Djokic-Gallagher, Jasmina Rosher, Philip Walker, Jennine Sykes, Krystyna Hart, Valerie |
author_facet | Djokic-Gallagher, Jasmina Rosher, Philip Walker, Jennine Sykes, Krystyna Hart, Valerie |
author_sort | Djokic-Gallagher, Jasmina |
collection | PubMed |
description | Objective: The aim of this study was to compare the moisturising efficacy and acceptability of physical characteristics of two commonly prescribed emollients licenced in the UK, Doublebase Dayleve gel (DELP) and Diprobase cream (DIPC). Methods: The study was a double-blind, concurrent bi-lateral comparison in female eczema subjects with dry skin. Results: In Part 1, comparing the area under the curve (AUC) change from baseline corneometer readings over 24 h following single applications of the emollients to the volar forearms of 34 subjects, the AUC for DELP was more than three times that seen for DIPC (p < 0.0001). In Part 2, comparing the same outcome measured over 5 days of twice daily applications to the lower legs in 36 subjects, the AUC for DELP was approximately five times that for DIPC (p < 0.0001). 69% of subjects “Like Slightly” or “Like Strongly” DELP compared to 33% for DIPC (p = 0.025). 72% indicated they would use DELP again compared to 33% for DIPC (p = 0.033). 75% of subjects preferred DELP, 17% preferred DIPC and 8% expressed no preference (p = 0.0004). |
format | Online Article Text |
id | pubmed-5020331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-50203312016-09-29 Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products Djokic-Gallagher, Jasmina Rosher, Philip Walker, Jennine Sykes, Krystyna Hart, Valerie J Dermatolog Treat Eczema Objective: The aim of this study was to compare the moisturising efficacy and acceptability of physical characteristics of two commonly prescribed emollients licenced in the UK, Doublebase Dayleve gel (DELP) and Diprobase cream (DIPC). Methods: The study was a double-blind, concurrent bi-lateral comparison in female eczema subjects with dry skin. Results: In Part 1, comparing the area under the curve (AUC) change from baseline corneometer readings over 24 h following single applications of the emollients to the volar forearms of 34 subjects, the AUC for DELP was more than three times that seen for DIPC (p < 0.0001). In Part 2, comparing the same outcome measured over 5 days of twice daily applications to the lower legs in 36 subjects, the AUC for DELP was approximately five times that for DIPC (p < 0.0001). 69% of subjects “Like Slightly” or “Like Strongly” DELP compared to 33% for DIPC (p = 0.025). 72% indicated they would use DELP again compared to 33% for DIPC (p = 0.033). 75% of subjects preferred DELP, 17% preferred DIPC and 8% expressed no preference (p = 0.0004). Taylor & Francis 2016-09-02 2016-02-10 /pmc/articles/PMC5020331/ /pubmed/26864095 http://dx.doi.org/10.3109/09546634.2015.1136384 Text en © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Eczema Djokic-Gallagher, Jasmina Rosher, Philip Walker, Jennine Sykes, Krystyna Hart, Valerie Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products |
title | Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products |
title_full | Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products |
title_fullStr | Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products |
title_full_unstemmed | Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products |
title_short | Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products |
title_sort | emollient efficacy and acceptability in the treatment of eczematous dry skin: a double-blind, randomised comparison of two uk-marketed products |
topic | Eczema |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020331/ https://www.ncbi.nlm.nih.gov/pubmed/26864095 http://dx.doi.org/10.3109/09546634.2015.1136384 |
work_keys_str_mv | AT djokicgallagherjasmina emollientefficacyandacceptabilityinthetreatmentofeczematousdryskinadoubleblindrandomisedcomparisonoftwoukmarketedproducts AT rosherphilip emollientefficacyandacceptabilityinthetreatmentofeczematousdryskinadoubleblindrandomisedcomparisonoftwoukmarketedproducts AT walkerjennine emollientefficacyandacceptabilityinthetreatmentofeczematousdryskinadoubleblindrandomisedcomparisonoftwoukmarketedproducts AT sykeskrystyna emollientefficacyandacceptabilityinthetreatmentofeczematousdryskinadoubleblindrandomisedcomparisonoftwoukmarketedproducts AT hartvalerie emollientefficacyandacceptabilityinthetreatmentofeczematousdryskinadoubleblindrandomisedcomparisonoftwoukmarketedproducts |